Skip to main content
. 2018 Jan 1;9(1):205–212. doi: 10.7150/jca.21414

Figure 3.

Figure 3

Ki67+CD8+ T cell reinvigoration and therapy efficacy. A: Example of Ki67 expression in peripheral blood CD8+ T cells; B and C: In the samples of 6 patients, there were no trends of correlation among therapy response, ratio of Ki67+CD8+ T cell reinvigoration to tumor burden, pre- or post- immunotherapy.